Neurocognitive outcome in survivors of pediatric cancer

Current Opinion in Pediatrics

Volumn 23, Issue 1, 2011, Pages 27-33

  Winick, Naomi ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

neurocognitive dysfunction; pediatric cancer; risk factors

Indexed keywords

METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; COGNITIVE DEFECT; HIGH RISK POPULATION; HUMAN; NEUROTOXICITY; NONHUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PHARMACOGENOMICS; PRIORITY JOURNAL; RADIATION HAZARD;

ANIMALS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; COGNITION DISORDERS; HUMANS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SURVIVORS;

EID: 78751625619     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e32834255e9     Document Type: Article

References (67)

1. Henderson TO, Friedman DL, Meadows AT. Childhood cancer survivors: transition to adult-focused risk-based care. Pediatrics 2010; 126:129-136.
2. Oeffinger KC, Nathan PC, Kremer LC. Challenges after curative treatment for childhood cancer and long-term follow up of survivors. Hematol Oncol Clin North Am 2010; 24:129-149.
3. Kadan-Lottick NS, Zeltzer LK, Liu Q, et al. Neurocognitive functioning in adult survivors of childhood noncentral nervous system cancers. J Natl Cancer Inst 2010; 102:881-893.
4. Zeltzer LK, Recklitis C, Buchbinder D, et al. Psychological status in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2009; 27:2396-2404.
5. Turner CD, Rey-Casserly C, Liptak CC, Chordas C. Late effects of therapy for pediatric brain tumor survivors. J Child Neurol 2009; 24:1455-1463.
6. Armstrong GT, Liu Q, Yasui Y, et al. Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study. J Natl Cancer Inst 2009; 101:946-958.
7. Nathan PC, Patel SK, Dilley K, et al. Guidelines for identification of, advocacy for, and intervention in neurocognitive problems in survivors of childhood cancer: a report from the Children's Oncology Group. Arch Pediatr Adolesc Med 2007; 161:798-806.
8. Ellenberg L, Liu Q, Gioia G, et al. Neurocognitive status in long-term survivors of childhood CNS malignancies: a report from the Childhood Cancer Survivor Study. Neuropsychology 2009; 23:705-717.
9. Aarsen FK, Paquier PF, Arts WF, et al. Cognitive deficits and predictors years after diagnosis of a pilocytic astrocytoma in childhood. J Clin Oncol 2009; 27:3526-3532.
10. Mabbott DJ, Penkman L, Witol A, et al. Core neurocognitive functions in children treated for posterior fossa tumors. Neuropsychology 2008; 22:159-168.
11. Calabrese P, Schlegel U. Neurotoxicity of treatment. Recent Results Cancer Res 2009; 171:165-174.
12. Armstrong GT, Jain N, Liu W, et al. Region-specific radiotherapy and neuropsychological outcomes in adult survivors of childhood CNS malignancies. Neuro Oncol 2010; 12:1173-1186
13. Bhatia S, Constine LS. Late morbidity after successful treatment of children with cancer. Cancer J 2009; 15:174-180.
14. Askins MA, Moore BD 3rd. Preventing neurocognitive late effects in childhood cancer survivors. J Child Neurol 2008; 23:1160-1171.
15. Reeves CB, Palmer SL, Reddick WE, et al. Attention and memory functioning among pediatric patients with medulloblastoma. J Pediatr Psychol 2006; 31:272-280.
16. Gurney JG, Kadan-Lottick NS, Packer RJ, et al. Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer 2003; 97:663-673.
17. Mody R, Li S, Dover DC, et al. Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Blood 2008; 111:5515-5523.
18. Reimers TS, Ehrenfels S, Mortensen EL, et al. Cognitive deficits in long-term survivors of childhood brain tumors: identification of predictive factors. Med Pediatr Oncol 2003; 40:26-34.
19. Maddrey AM, Bergeron JA, Lombardo ER, et al. Neuropsychological performance and quality of life of 10 year survivors of childhood medulloblastoma. J Neurooncol 2005; 72:245-253.
20. Farber S, Diamond LK, Mercer RD. Temporary remissions in acute leukemia in children produced by folic acid antagonist 4-aminopteroylglutamic acid (aminopterin). N Engl J Med 1948; 238:787-793.
21. Simone J, Aur RJ, Hustu HO, et al. Total therapy? studies of acute lymphocytic leukemia in children. Current results and prospects for cure. Cancer 1972; 30:1488-1494.
22. Schrappe M, Nachman J, Hunger S, et al. Educational symposium on longterm results of large prospective clinical trials for childhood acute lymphoblastic leukemia (1985-2000). Leukemia 2010; 24:253-254.
23. Pui CH, Campana D, Pei D, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 2009; 360:2730-2741.
24. Moleski M. Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Arch Clin Neuropsychol 2000; 15:603-630.
25. Spiegler BJ, Kennedy K, Maze R, et al. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate. J Clin Oncol 2006; 24:3858-3864.
26. Campbell LK, Scaduto M, Sharp W, et al. A meta-analysis of the neurocognitive sequelae of treatment for childhood acute lymphocytic leukemia. Pediatr Blood Cancer 2007; 49:65-73.
27. Harila MJ, Winqvist S, Lanning M, et al. Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2009; 53:156-161.
28. Jansen NC, Kingma A, Schuitema A, et al. Neuropsychological outcome in chemotherapy-only-treated children with acute lymphoblastic leukemia. J Clin Oncol 2008; 26:3025-3030.
29. Anderson FS, Kunin-Batson AS. Neurocognitive late effects of chemotherapy in children: the past 10 years of research on brain structure and function. Pediatr Blood Cancer 2009; 52:159-164.
30. Lofstad GE, Reinfjell T, Hestad K, et al. Cognitive outcome in children and adolescents treated for acute lymphoblastic leukaemia with chemotherapy only. Acta Paediatr 2009; 98:180-186.
31. Buizer AI, de Sonneville LM, Veerman AJ. Effects of chemotherapy on neurocognitive function in children with acute lymphoblastic leukemia: a critical review of the literature. Pediatr Blood Cancer 2009; 52:447-454.
32. Ashford J, Schoffstall C, Reddick WE, et al. Attention and working memory abilities in children treated for acute lymphoblastic leukemia. Cancer 2010; 116:1173-1186.
33. von der Weid N, Mosimann I, Hirt A, et al. Intellectual outcome in children and adolescents with acute lymphoblastic leukaemia treated with chemotherapy alone: age- and sex-related differences. Eur J Cancer 2003; 39:359-365.
34. Reddick WE, Laningham FH, Glass JO, et al. Quantitative morphologic evaluation of magnetic resonance imaging during and after treatment of childhood leukemia. Neuroradiology 2007; 49:889-904.
35. Wilson DA, Nitschke R, Bowman ME, et al. Transient white matter changes on MR images in children undergoing chemotherapy for acute lymphocytic leukemia: correlation with neuropsychologic deficiencies. Radiology 1991; 180:205-209.
36. Janzen LA, Spiegler BJ. Neurodevelopmental sequelae of pediatric acute lymphoblastic leukemia and its treatment. Dev Disabil Res Rev 2008; 14:185-195.
37. Aukema EJ, Caan MW, Oudhuis N, et al. White matter fractional anisotropy correlates with speed of processing and motor speed in young childhood cancer survivors. Int J Radiat Oncol Biol Phys 2009; 74:837-843.
38. Robinson KE, Livesay KL, Campbell LK, et al. Working memory in survivors of childhood acute lymphocytic leukemia: functional neuroimaging analyses. Pediatr Blood Cancer 2010; 54:585-590.
39. Correa DD, Ahles TA. Neurocognitive changes in cancer survivors. Cancer J 2008; 14:396-400.
40. Robaey P, Krajinovic M, Marcoux S, et al. Pharmacogenetics of the neurodevelopmental impact of anticancer chemotherapy. Dev Disabil Res Rev 2008; 14:211-220.
41. Kadan-Lottick NS, Brouwers P, Breiger D, et al. A comparison of neurocognitive functioning in children previously randomized to dexamethasone or prednisone in the treatment of childhood acute lymphoblastic leukemia. Blood 2009; 114:1746-1752.
42. Cole PD, Kamen BA. Delayed neurotoxicity associated with therapy for children with acute lymphoblastic leukemia. Ment Retard Dev Disabil Res Rev 2006; 12:174-183.
43. Schmiegelow K. Advances in individual prediction of methotrexate toxicity: a review. Br J Haematol 2009; 146:489-503.
44. Kishi S, Griener J, Cheng C, et al. Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia. J Clin Oncol 2003; 21:3084-3091.
45. Caron JE, Krull KR, Hockenberry M, et al. Oxidative stress and executive function in children receiving chemotherapy for acute lymphoblastic leukemia. Pediatr Blood Cancer 2009; 53:551-556.
46. Motsinger-Reif AA, Jorgenson E, Relling MV, et al. Genome-wide association studies in pharmacogenomics: successes and lessons. Pharmacogenet Genomics 2010. [Epub ahead of print]
47. Relling MV, Altman RB, Goetz MP, et al. Clinical implementation of pharmacogenomics: overcoming genetic exceptionalism. Lancet Oncol 2010; 11:507-509.
48. Krull KR, Brouwers P, Jain N, et al. Folate pathway genetic polymorphisms are related to attention disorders in childhood leukemia survivors. J Pediatr 2008; 152:101-105.
49. Krajinovic M, Robaey P, Chiasson S, et al. Polymorphisms of genes controlling homocysteine levels and IQ score following the treatment for childhood ALL. Pharmacogenomics 2005; 6:293-302.
50. Vardy J, Wefel JS, Ahles T, et al. Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol 2008; 19:623-629.
51. Winocur G, Vardy J, Binns MA, et al. The effects of the anticancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice. Pharmacol Biochem Behav 2006; 85:66-75.
52. Gandal MJ, Ehrlichman RS, Rudnick ND, et al. A novel electrophysiological model of chemotherapy-induced cognitive impairments in mice. Neuroscience 2008; 157:95-104.
53. Veerman AJ, Kamps WA, van den Berg H, et al. Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997- 2004). Lancet Oncol 2009; 10:957-966.
54. Grill J, Sainte-Rose C, Jouvet A, et al. Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children. Lancet Oncol 2005; 6:573-580.
55. Oyharcabal-Bourden V, Kalifa C, Gentet JC, et al. Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study. J Clin Oncol 2005; 23:4726-4734.
56. Conklin HM, Li C, Xiong X, et al. Predicting change in academic abilities after conformal radiation therapy for localized ependymoma. J Clin Oncol 2008; 26:3965-3970.
57. Conklin HM, Khan RB, Reddick WE, et al. Acute neurocognitive response to methylphenidate among survivors of childhood cancer: a randomized, doubleblind, cross-over trial. J Pediatr Psychol 2007; 32:1127-1139.
58. Mulhern RK, Khan RB, Kaplan S, et al. Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer. J Clin Oncol 2004; 22:4795-4803.
59. Daly BP, Brown RT. Scholarly literature review: management of neurocognitive late effects with stimulant medication. J Pediatr Psychol 2007; 32:1111-1126.
60. Askins MA, Sahler OJ, Sherman SA, et al. Report from a multiinstitutional randomized clinical trial examining computer-assisted problem-solving skills training for English- and Spanish-speaking mothers of children with newly diagnosed cancer. J Pediatr Psychol 2009; 34:551-563.
61. Moore IM, Hockenberry M, Kaemingk K, et al. Math intervention for children with acute lymphoblastic leukemia. Oncol Nurs Forum 2005; 32:168.
62. Butler RW, Sahler OJ, Askins MA, et al. Interventions to improve neuropsychological functioning in childhood cancer survivors. Dev Disabil Res Rev 2008; 14:251-258.
63. Butler RW, Copeland DR, Fairclough DL, et al. A multicenter, randomized clinical trial of a cognitive remediation program for childhood survivors of a pediatric malignancy. J Consult Clin Psychol 2008; 76:367-378.
64. Kerns KA, Eso K, Thomson J. Investigation of a direct intervention for improving attention in young children with ADHD. Develop Neuropsychol 1999; 16:273-295.
65. Klingberg T, Fernell E, Olesen PJ, et al. Computerized training of working memory in children with ADHD: a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 2005; 44:177-186.
66. Westerberg H, Jacobaeus H, Hirvikoski T, et al. Computerized working memory training after stroke: a pilot study. Brain Inj 2007; 21:21-29.
67. Hardy K, Willard V, Bonner M. Computerized cognitive training in survivors of childhood cancer: a pilot study. J Pediatric Oncol Nurs 2010. [Epub ahead of print]